Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity
Investigational New Drugs
Oppegard, LMDelgado, JLKulkarni, CATowle, TRHart, DEWilliams, BPLentz, SRNorris, BJFlory, CMSchumacher, RJMurry, DJKerns, RJHiasa, H
Article co-written by College of Health and Wellness faculty member Lisa Oppegard.
Topoisomerase IIColon cancerFluoroquinolonesTopoisomerase I
Copyright to this work is held by the author(s), in accordance with United States copyright law (USC 17). Readers of this work have certain rights as defined by the law, including but not limited to fair use (17 USC 107 et seq.). Questions regarding copyright and use issues should be directed to the publishers or rights holders of each individual work. Questions regarding this collection may be directed to the Northwestern Health Sciences University Greenawalt Library at 952-885-5419 or at firstname.lastname@example.org.
Northwestern Health Sciences University